fda bpc-157 warning not approved human use panel votes to place popular peptide on compounding list bpc-157 human clinical trials safety

This process is analyzed in relation to VEGFR2 signaling, Akt/eNOS pathways, endothelial cell survival, and the regulation of repair mechanisms in connective tissues

No registered Phase I, II, or III human clinical trials for BPC-157 appear in ClinicalTrials.gov as of 2026a critical gap

What list inclusion would not permit Even a final listing would not turn BPC-157 into an over-the-counter supplement, authorize unrestricted bulk manufacturing, or validate every advertised claim

Not recommended for pregnant or nursing mothers

Similar symptoms can come from active inflammation, IBS overlap, infection, bile acid diarrhoea, small intestinal bacterial overgrowth, food intolerance, medication effects or other causes

Its known to assist with fat burning and metabolism, as well as helping to regulate appetite and sleep patterns